SavedAdd your journal

Journals / Annals of Medical Research / 2021 / Cilt: 28 - Sayı: 1

Assessment of pulmonary functions with spirometry method in hepatic impairment patients

Necmiye Funda COŞKUN
Selim Giray NAK
Fadil ÖZYENER
Sadettin DEMİREL
Pages
106–112
Publication Date
2022-10-12
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The significance levelwas considered as p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aim: In this study, it has been aimed to investigate whether there is a relationship between pulmonary functions measured by spirometry and hepatic impairment tables.
📊
Key Findings & Data:This may contribute to a better understanding of the mechanisms of liver pathophysiology which hasn’t been fully understood.Materials and Methods: This study is a randomized controlled prospective trial. 39-63 years of age, 19 male and 9 female, a total of 28 patients diagnosed with liver failure, with 15 male and 17 female, a total of 32 healthy volunteers with similar social characteristics were studied.
💡
Conclusion & Impact:The significance levelwas considered as p
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Aim: In this study, it has been aimed to investigate whether there is a relationship between pulmonary functions measured by spirometry and hepatic impairment tables. This may contribute to a better understanding of the mechanisms of liver pathophysiology which hasn’t been fully understood.Materials and Methods: This study is a randomized controlled prospective trial. 39-63 years of age, 19 male and 9 female, a total of 28 patients diagnosed with liver failure, with 15 male and 17 female, a total of 32 healthy volunteers with similar social characteristics were studied. All of the participants’ pulmonary parameters (FEV1, FVC, FEV1/FVC, PEF, FEF25-75%, FEF25%, FEF50%, FEF75%, PIF, VC, MVV) were performed by pulmonary function tests (PFT). Groups’ data have been analyzed statistically. The significance levelwas considered as p

🔖

Cite This Article

COŞKUN, N. F., NAK, S. G., ÖZYENER, F., DEMİREL, S. (2022). Assessment of pulmonary functions with spirometry method in hepatic impairment patients. Annals of Medical Research, Cilt: 28 - Sayı: 1, 106–112. https://ajindex.com/articles/445859

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (18)

  1. Manns MP, Burra P, Sargent J, et al. The Lancet-EASL Commission on liver diseases in Europe: Overcoming unmet needs, stigma, and inequities. Lancet 2018;392:621-2
  2. Ramachandran A, Jaeschke H. Acetaminophen hepatotoxicity. Semin Liver Dis 2019;39:221-34
  3. Lima LCD, Miranda AS, Ferreira RN, et al. Hepatic encephalopathy: Lessons from preclinical studies. World J Hepatol 2019;11:173-85
  4. Chauhan A, Webb G, Ferguson J. Clinical presentations of Hepatitis E: A clinical review with representative case histories. Clin Res Hepatol Gastroenterol 2019;43:649-57
  5. Artzner T, Michard B, Besch C, et al. Liver transplantation for critically ill cirrhotic patients: Overview and pragmatic proposals. World J Gastroenterol 2018;24:5203-14
  6. Murphy N, Auzinger G, Bernel W, et al. The effect of hypertonic sodium chloride on intracranial pressure in patients with acute liver failure. Hepatology 2004;39:464-70
  7. Machicao VI, Balakrishnan M, Fallon MB. Pulmonary complications in chronic liver disease. Hepatology 2014;59:1627-37
  8. Mızrak D, İdilman R. Karaciğer nakli: Hasta seçimi, gelişen endikasyonlar. Türkiye Klinikleri J Gen Surg 2009;2:10-3
  9. Yalçın K. Karaciğer hastalıklarında semptomlar. In: Değertekin H, Yalçın K, eds. Karaciğer Hastalıklarına Klinik Yaklaşım. 1st edition. İstanbul: Pars Yayıncılık; 2009. p. 29-36
  10. Krowka MJ, Cortese DA. Pulmonary aspects of chronic liver disease and liver transplantation. Mayo Clin Proc 1985;60:407-18
  11. Çağlar T, Ilgaz A. Solunum Fonksiyon Testleri ve Klinik Kullanımı. 1st edition. Nobel Tıp Kitabevi, İstanbul, 2004; 1-102
  12. Miller MR, Hankinson J, Brusasco V, et al. ATS/ERS Task Force. Standardisation of spirometry. Eur Respir J 2005;26:319-38
  13. Rodriguez-Roisin R, Bartolome SD, Huchon G, et al. Inflammatory bowel diseases, chronic liver diseases and the lung. Eur Respir J 2016;47:638-50
  14. Krovvka MJ, Cortese DA. Hepatopulmonary syndrome: An evolving perspective in the era of liver transplantation. Hepatology 1990;11:138-42
  15. Krovvka MJ, Cortese DA. Hepatopulmonary syndrome: Current concept in diagnostic and therapeutic considerations. Chest 1994;105:1528-37
  16. Rodriguez-Roisin R, Agusti AGN, Roca J. The hepatopulmonary syndrome: New name, old complexities. Thorax 1992;47:897-902
  17. Kennedy TC, Knudson RL. Exercise-aggravated hypoxemia and orthodeoxia in cirrhosis. Chest 1977;72:305-9
  18. Osni Leão Perin P, de Fátma Ferreira Santana Boin I, Oliveira da Silva AM, et al. Lung ultrasound and pulm